Market Alert: Trump Revives Trade War Playbook with Tariff Threats
In the September 2024 quarter, Law Finance Limited (ASX: LAW) reported a subdued operational performance as it continues to wind down legacy operations and pursue future prospects. The company collected US$0.5 million from its PFG loan receivables portfolio, down from the previous quarter, reflecting a shrinking book. No new claim originations occurred during the quarter. Operational focus remained on advancing the Trident HG joint venture in the U.S. healthcare sector, though the timeline for its first hospital funding agreement remains uncertain. Operating expenditure decreased sharply to just US$5,000 per month due to the absence of staff and office overheads. Cash outflows were minimal, with net operating cash inflow of US$21,000 and quarter-end cash reserves standing at US$53,000. No financing activity or related party payments were recorded. While the company remains suspended from trading, it continues to explore strategic options for revitalization through the Trident initiative.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.